Enabling Immunotherapy for Liver Tumors

  • Registration Closed
 MODERATORSteven C. Katz, MD, FACS
SPEAKERSSteven C. Katz, MD, FACS

Alex Kim, MD

Rahul Sheth, MD

Key:

Complete
Failed
Available
Locked
Enabling Immunotherapy for Liver Tumors
Recorded 09/20/2022
Recorded 09/20/2022 Explore the emerging topic of immunotherapy as a treatment for liver tumors with experts from TriSalus Life Sciences.
You must register to access.